· The team founded GemPharmatech Co. Ltd.
· Started Knock-Out All Project, aiming to establish a comprehensive knock out strain library of all coding gene in mice and accelerating the global life science research.
· Built humanized animal models and pharmacology system, assisting the development of new drugs;
· Established Changzhou branch, expanding the production capacity；
· Organized the national sales force in China;
· Closed Series A funding.
· Created over 14,000 gene knockout strains within the Knock-Out All Project, owning the world's top 3 mice strain resources.
· Obtained the Germ-Free Animal Production License;
· Put Chengdu and Guangdong production bases into operation, developing a national layout in China;
· Established subsidiary in Boston, U.S. and built the sales network in America, Europe and Southeast Asia, marching into the international market;
· Closed Series B funding.